Does ABIRATERONE Cause Neoplasm malignant? 138 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Neoplasm malignant have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.4% of all adverse event reports for ABIRATERONE.
138
Reports of Neoplasm malignant with ABIRATERONE
0.4%
of all ABIRATERONE reports
51
Deaths
29
Hospitalizations
How Dangerous Is Neoplasm malignant From ABIRATERONE?
Of the 138 reports, 51 (37.0%) resulted in death, 29 (21.0%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ABIRATERONE Alternatives Have Lower Neoplasm malignant Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB